Chemical Peel Market Report Scope & Overview:
The chemical peel market size was valued at USD 2.18 billion in 2024 and is expected to reach USD 3.23 billion by 2032, growing at a CAGR of 5.09% over the forecast period of 2025-2032.
The global chemical peel market is growing substantially owing to the growing preference for non-invasive aesthetic techniques, the rising prevalence of acne, hyperpigmentation, and aging of the skin. Rising consumer awareness and a proliferation of aesthetic clinics, and the development of new peel formulations are driving the chemical peel market growth. Moreover, increasing demand for personalized & at-home peel products is also strengthening the market growth in developed as well as emerging countries.
The U.S. chemical peel market size was valued at USD 0.70 billion in 2024 and is expected to reach USD 1.01 billion by 2032, growing at a CAGR of 4.70% over the forecast period of 2025-2032.
The North American chemical peel market is dominated by the U.S., due to robust consumer demand for cosmetic procedures, strong presence of dermatology clinics, and early access to cutting-edge peel technologies. The nation continues to set cosmetic dermatology trends and innovations for the region.
Market Dynamics:
Drivers
-
A Growing Share of Minimally Invasive Cosmetic Procedures is Expected to Boost Market Growth
Chemical peels are being used as a trend towards non- and minimally invasive cosmetic treatments. More and more people are turning to non-invasive treatments that offer noticeable improvements to the skin, reducing acne scars, wrinkles, or pigmentation, all with no scalpel and next to no downtime. Chemical peels provide a relatively inexpensive and rapid treatment with less painful side effects, presenting an attractive option to patients who want skin rejuvenation. This demand has been fueled, in part, by the global trend towards preventive skin care and aesthetic improvements.
-
Technological Advancements in Peel Formulations are Accelerating the Market Growth
With the development of newer formulations, chemical peels have become safer, more flexible, and applicable to a wider variety of skin. The current peels are far more advanced and contain combinations of alpha hydroxy acids (AHAs), beta hydroxy acids (BHAs), trichloroacetic acid (TCA), and other actives that allow dermatologists to customise treatments according to a patient’s skin concern(s). Next-gen peels are designed to reduce irritation while providing results such as better skin texture, tone, and hydration. These advancements have led to greater patient satisfaction and expanded the use of chemical peels in both the in-office and at-home settings.
Restraint
-
Side Effects and Post-Treatment Complications Restraining the Market Growth
One of the major challenges in the chemical peel market is the side effects and post-treatment complications, which can be caused if the procedures are not carried out properly or if the type of peels used does not suit the patient's skin tone or condition. And deeper chemical peels that reach deeper layers of the skin have risks, including redness that can last for weeks, scarring, infection, and changes in skin color — either hyperpigmentation (dark spots) or hypopigmentation (light spots).
These adverse effects are most problematic in darker skin types, in which pigment-related complications are a concern. The possibility of such outcomes can deter consumers from seeking and providers from providing the treatments, especially where follow-up or post-treatment support is lacking. The use of at-home peel products without professional guidance also carries the risk of inappropriate use and skin injury, supporting the recommendation to use chemical peels judiciously.
Segmentation Analysis:
By Product
The fruit peel segment dominated the chemical peel market share in 2024 with a 24.10%, a natural-based formula, and the gentle form of exfoliation. All fruit peels are derived from alpha hydroxy acids (AHAs) found in fruit such as citric, malic, and glycolic acid. Fruit peels are one of the preferred peels for their safety, little to no downtime, and for being safe for all skin types. They are especially well-loved in clinical and at-home settings for dullness, slight pigmentation, and the first signs of aging. The increased focus on natural botanical skin care solutions also helped to bolster the segment's presence in the market, particularly among consumers who wanted non-compromising treatments with visible but gentle skin results.
The lactic peel segment is projected to be the fastest growing during the forecast period on account of the growing popularity of sensitive skin exfoliation, followed by moisturizing performance. Lactic acid, a gentler AHA that comes from milk, still packs a punch – it's incredibly effective at treating dry skin, fine lines, and an uneven texture while also keeping skin hydrated – ideal for those with rosacea, eczema-prone skin, or first-time AHA users. The increasing use of this as an ingredient in dermatologic offices and over-the-counter skincare formulations, accompanied by the increased focus on maintaining the skin barrier, is driving its incorporation. The rise of gentle, moisturizing peels in the context of growing over-exfoliation will help propel the growth of this segment at a fast pace.
By Type
The superficial or light peel segment dominated the chemical peel market in 2024 due to its high adoption, low-risk profile, and growing number of individuals willing to undergo superficial peels. These peels, which usually have low levels of both alpha and beta hydroxy acids, exfoliate the outermost layer of skin and are useful in treating common complaints such as acne, dull complexion, and mild pigmentation. They have less downtime and less risk of side effects, so they are safe to use more frequently and for all skin types, including as part of your home care program. The prevalence of the segment is further fuelled by its cost-effectiveness and availability, both popular among first-time users and aesthetic specialists.
The medium peel segment is likely to be the fastest-growing over the forecast period in the chemical peel market analysis, as there is an escalating trend for the need for more precise and long-lasting treatment for moderate skin problems such as wrinkles, acne scars, and deeper pigmentation. Medium peels reach down deeper into the epidermis and to the upper parts of the dermis, giving you clearer, tighter, and improving skin tone and texture in less time than it takes with a light peel. With increasing patient confidence in chemical peeling and aesthetic interest globally, there is an increasing demand for moderate-depth peeling, combining effectiveness with acceptable post-procedure downtime. The development of new formulations and techniques has also rendered the medium-depth peels safer and more modifiable, which has broadly increased demand in a clinical setting.
By Application
The acne spots segment dominated the chemical peel market in 2024 rising prevalence of acne across the globe, especially among adolescents and young adults. Chemical peels (particularly ones with salicylic acid and glycolic acid) are mainstays for alleviating post-acne hyperpigmentation and leftover spots, encouraging quicker turnover of skin cells and clearing out pores. This division has strong demand across clinical dermatology and over-the-counter skincare markets. In addition, awareness of problems concerned with acne skin, influences, and the tendency that clear skin without stain becomes important, increases the use of chemical peels for acne spots.
The dark circles segment is expected to be the fastest-growing application segment over the forecast period on the back of escalating concerns about tired-looking eyes and periorbital pigmentation being witnessed in individuals, particularly among the working population and geriatric population. Screen time, as well as stress and lifestyle factors that affect under-eye appearance, mean that consumers are now seeking effective and targeted chemical peels as a non-invasive answer. Mild peels containing lactic acid, kojic acid, and other skin-brightening ingredients are also increasing in popularity for under-eye use, particularly in med spas and dermatologists’ offices. The move towards holistic facial rejuvenation and the increased popularity of aesthetic eye surgery are anticipated to have a positive impact on the growth of the segment.
By End Use
The dermatology clinics segment led the chemical peel market in 2024 with a 72.2% market share. High consumer faith in certified medical professionals for skin treatments. What dermatologists provide is medically supervised and accurate skin assessment and preparation of a peel based on specific skin needs, making the process safer and more effective, where medium and deep peels are concerned. These centers are equipped to treat a wide spectrum of skin issues, such as acne scars, melasma, and photoaging, and attract people looking for professional-level results. Moreover, the increasing incidence of skin disorders and increasing inclination toward tailored aesthetic treatments contributed to the large share captured by this segment.
The med spa segment is the fastest growing in the forecast period on account of rising demand for wellness and non-invasive cosmetic services available in a serene and luxury-focused setting. The med spa allows clients to spruce up with skin-brightening chemical peels for all skin types, from anti-aging solutions to acne management, while maintaining a competitive price. Growing into metropolitan and suburban markets, offering shorter treatment times and flexible scheduling, is appealing to a broader audience, including younger patients. Combine this with sophisticated skincare technologies and appealing treatment offers, and this sector continues to grow, especially among those wanting regular, maintenance-led cosmetic treatments.
Regional Analysis:
North America dominated the chemical peel market with a 42.3% market share in 2024 as a result of superlative healthcare facilities, easy access to dermatology & cosmetic clinics, and higher non-surgical cosmetic treatments opting among the consumers. The area enjoys robust demand for anti-aging therapies and skin revitalization, in particular for middle-aged and senior residents. In addition to this, the availability of leading skincare and aesthetics brands, regular product launches, and conducive regulatory frameworks are also contributing to the dominance of this region. Rising consumer spending on premium skincare products and increasing self-care and appearance-enhancement trends continue to boost the market.
Asia Pacific is the fastest growing region for the chemical peel market with a 5.62% CAGR over the forecast period, with a deeper coverage on the regions, and is the most prone to growth activities owing to rises in a large population, developing disposable incomes increasing beauty consciousness, especially in China, India, South Korea, and Japan. The societal fascination with perfect skin, combined with social media and K-beauty trendsetters, is fueling demand for cosmetic dermatology. Furthermore, the proliferation of aesthetic clinics, the rise in medical tourism, and the rise in accessibility of peel procedures at affordable prices further contribute to market expansion. Younger population in the area due to increasing levels of urbanization also continues to fuel the demand for the chemical peels market.
There is a substantial growth in the chemical peel market trends in Europe due to increasing consciousness on skin health, a rise in demand for non-surgical cosmetic treatments, and developing beauty and wellness trends. Germany, France, and the U.K. have been dominating the region with the availability of advanced dermatology centers and increased focus on skin care advancements. The aging population, along with widespread use of anti-aging treatments, is driving the use of chemical peels in both medical and spa facilities.
Latin America and the Middle East & Africa (MEA) have moderate growth in the chemical peel market due to increasing urbanization and growing cosmetic surgery-related markets. In Latin America, a rising beauty culture and easier access to aesthetic treatments at affordable prices have seen high demand in countries. In the MEA, market development in the UAE and South Africa is increasing steadily, and overall expansion has been somewhat constrained by the scarcity of premium skincare facilities in certain countries.
Key Players:
Allergan (AbbVie Inc.), L’Oréal S.A., Procter & Gamble, Johnson & Johnson, Pierre Fabre Group, The Estée Lauder Companies Inc., Obagi Medical, Epionce, NeoStrata Company Inc., IMAGE Skincare, DERMAdoctor LLC, Murad LLC, Replenix, ZO Skin Health Inc., Glytone, SkinCeuticals, Alma Lasers, Vivier Pharma, Dermalogica, SkinMedica, and other players.
Recent Developments:
-
January 2025 – The Estée Lauder Companies Inc. (ELC) has revealed a strategic partnership with the Massachusetts Institute of Technology (MIT), together collaborating on the laboratory of renowned scientist Dr. Robert Langer. The partnership is designed to enhance leading-edge research and innovation in the cosmetics industry.
-
May 2023 – AbbVie's Allergan Aesthetics business announced that the U.S. Food and Drug Administration (FDA) has approved SKINVIVE by JUVÉDERM. This treatment is the first and only hyaluronic acid (HA)-based intradermal microdroplet injection approved in the United States to improve skin smoothness in adult cheeks of individuals aged 21 and older.
| Report Attributes | Details |
|---|---|
| Market Size in 2024 | USD 2.18 Billion |
| Market Size by 2032 | USD 3.23 Billion |
| CAGR | CAGR of 5.09% From 2025 to 2032 |
| Base Year | 2024 |
| Forecast Period | 2025-2032 |
| Historical Data | 2021-2023 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Product (Lactic Peel, Fruit Peel, Salicylic Acid Peel, Pigment Balancing Peel [Customizable Chemical Peel], Trichloroacetic Acid Peel, Vitalize Peel) • By Type (Superficial or Light Peel, Medium Peel, Deep or Phenol Peel) • By Application (Acne Spots, Wrinkles, Fine Lines, Hyperpigmentation, Scars, Dark Circles, Skin Brightening, Others) • By End Use (Hospitals, Med Spa, Dermatology Clinics, Others) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Germany, France, UK, Italy, Spain, Poland, Turkey, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Allergan (AbbVie Inc.), L’Oréal S.A., Procter & Gamble, Johnson & Johnson, Pierre Fabre Group, The Estée Lauder Companies Inc., Obagi Medical, Epionce, NeoStrata Company Inc., IMAGE Skincare, DERMAdoctor LLC, Murad LLC, Replenix, ZO Skin Health Inc., Glytone, SkinCeuticals, Alma Lasers, Vivier Pharma, Dermalogica, SkinMedica, and other players. |